Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus

Somatostatin analogs mantain their major role in the treatment of patients with advanced neuroendocrine tumors (NETs) and have multiple modulatory effects on the immune system. Here, we evaluated the effects of lanreotide treatment on expression of Th1, Th2 cytokine patterns in serum of patients wit...

Full description

Saved in:
Bibliographic Details
Published in:Front Oncol
Main Authors: Sciammarella, Concetta, Luce, Amalia, Riccardi, Ferdinando, Mocerino, Carmela, Modica, Roberta, Berretta, Massimiliano, Misso, Gabriella, Cossu, Alessia Maria, Colao, Annamaria, Vitale, Giovanni, Necas, Alois, Fedacko, Jan, Galdiero, Marilena, Correale, Pierpaolo, Faggiano, Antongiulio, Caraglia, Michele, Capasso, Anna, Grimaldi, Anna
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7379869/
https://ncbi.nlm.nih.gov/pubmed/32766136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01047
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items